Published November 11, 2015 | Version v1
Journal article

Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?

  • 1. Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton (United Kingdom)
  • 2. Academic Urology Unit, Institute of Cancer Research, London (United Kingdom)

Description

The indications for post-prostatectomy radiotherapy have evolved over the last decade, although the optimal timing, dose, and target volume remain to be well defined. The target volume is susceptible to anatomical variations with its borders interfacing with the rectum and bladder. Image-guided intensity-modulated radiotherapy has become the gold standard for radical prostate radiotherapy. Here we review the current evidence for image-guided techniques with intensity-modulated radiotherapy to the prostate bed and describe current strategies to reduce or account for interfraction and intrafraction motion

Availability note (English)

Available from http://dx.doi.org/10.2147/CMAR.S51955; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646477

Additional details

Publishing Information

Journal Title
Cancer Management and Research
Journal Volume
7
Journal Page Range
p. 331-344
ISSN
1179-1322

INIS

Country of Publication
New Zealand
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47121513
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BLADDER; CURRENTS; GOLD; IMAGES; NEOPLASMS; PROSTATE; RADIATION DOSES; RADIOTHERAPY; RECTUM; STANDARDS
Descriptors DEC
BODY; DIGESTIVE SYSTEM; DISEASES; DOSES; ELEMENTS; GASTROINTESTINAL TRACT; GLANDS; INTESTINES; LARGE INTESTINE; MALE GENITALS; MEDICINE; METALS; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY; TRANSITION ELEMENTS; URINARY TRACT

Optional Information

Copyright
Copyright (c) 2015 Murray et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution #En Dash# Non Commercial (unported, v3.0) License
Notes
PMCID: PMC4646477; PMID: 26635484; PUBLISHER-ID: cmar-7-331; OAI: oai:pubmedcentral.nih.gov:4646477